[
  {
    "title": "百克生物(688276.SH)：魏学宁减持股份比例达1.0455%",
    "href": "http://stock.jrj.com.cn/2022/12/09154437201527.shtml",
    "datetime": "2022-12-09 15:44:55",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：减持数过半 股东魏学宁累计减持152.85万股",
    "href": "http://stock.jrj.com.cn/2022/12/06153837191871.shtml",
    "datetime": "2022-12-06 15:38:36",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：股东魏学宁自7月28日起已累计减持1.07%股份",
    "href": "http://stock.jrj.com.cn/2022/11/02160137106606.shtml",
    "datetime": "2022-11-02 16:01:41",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)第三季度净利润1.38亿元、同比增长46%",
    "href": "http://stock.jrj.com.cn/2022/10/27155737089626.shtml",
    "datetime": "2022-10-27 15:57:47",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：向108名激励对象授予272.30万股限制性股票",
    "href": "http://stock.jrj.com.cn/2022/10/17171937060850.shtml",
    "datetime": "2022-10-17 17:19:19",
    "code": "688276"
  },
  {
    "title": "长春高新(000661.SZ)：百克生物的天然全人源抗狂犬病毒单克隆抗体CBB1注射液临床试验申请获批",
    "href": "http://stock.jrj.com.cn/2022/10/10154837043796.shtml",
    "datetime": "2022-10-10 15:48:07",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：天然全人源抗狂犬病毒单克隆抗体CBB1注射液获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/10/10154737043797.shtml",
    "datetime": "2022-10-10 15:47:39",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：拟推2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/09/23164537017445.shtml",
    "datetime": "2022-09-23 16:45:38",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：魏学宁累计已减持200万股",
    "href": "http://stock.jrj.com.cn/2022/09/08153736983225.shtml",
    "datetime": "2022-09-08 15:37:14",
    "code": "688276"
  },
  {
    "title": "百克生物披露2022年半年报 实现营收4.41亿元",
    "href": "http://stock.jrj.com.cn/2022/08/26094236939341.shtml",
    "datetime": "2022-08-26 09:42:20",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)半年度净利润7357.17万元、同比下降46.83%",
    "href": "http://stock.jrj.com.cn/2022/08/25201536937137.shtml",
    "datetime": "2022-08-25 20:15:04",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：减持数过半 股东魏学宁已减持116.41万股",
    "href": "http://stock.jrj.com.cn/2022/08/04163536870426.shtml",
    "datetime": "2022-08-04 16:35:36",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：2021年年度权益分派10派1元 股权登记日7月14日",
    "href": "http://stock.jrj.com.cn/2022/07/07165436791221.shtml",
    "datetime": "2022-07-07 16:54:41",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)2021年度权益分派10派1元、股权登记日为7月14日",
    "href": "http://stock.jrj.com.cn/2022/07/07165436791222.shtml",
    "datetime": "2022-07-07 16:54:22",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：股东魏学宁拟减持不超200万股",
    "href": "http://stock.jrj.com.cn/2022/06/30161536771561.shtml",
    "datetime": "2022-06-30 16:15:25",
    "code": "688276"
  },
  {
    "title": "百克生物：约2.01亿股限售股将于6月27日解禁 占公司总股本比例48.57%",
    "href": "http://stock.jrj.com.cn/2022/06/17183036738937.shtml",
    "datetime": "2022-06-17 18:30:22",
    "code": "688276"
  },
  {
    "title": "A股异动丨百克生物大跌逾9% 澄清称目前没有预防猴痘病毒相关产品",
    "href": "http://stock.jrj.com.cn/2022/05/24110136673119.shtml",
    "datetime": "2022-05-24 11:01:51",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：公司目前没有预防猴痘病毒相关产品",
    "href": "http://stock.jrj.com.cn/2022/05/23214836671944.shtml",
    "datetime": "2022-05-23 21:48:54",
    "code": "688276"
  },
  {
    "title": "百克生物：目前没有预防猴痘病毒相关产品",
    "href": "http://stock.jrj.com.cn/2022/05/23183036671161.shtml",
    "datetime": "2022-05-23 18:30:22",
    "code": "688276"
  },
  {
    "title": "百克生物2022年第一季度净利1731.63万同比下滑68.76% 研发费用化支出增加",
    "href": "http://stock.jrj.com.cn/2022/05/03191136546525.shtml",
    "datetime": "2022-05-03 19:11:44",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)一季度净利润1731.63万元 同比下降68.76%",
    "href": "http://stock.jrj.com.cn/2022/04/27175436485054.shtml",
    "datetime": "2022-04-27 17:54:48",
    "code": "688276"
  },
  {
    "title": "长春高新(000661.SZ)：百克生物带状疱疹减毒活疫苗上市许可申请获受理",
    "href": "http://stock.jrj.com.cn/2022/04/06164436263069.shtml",
    "datetime": "2022-04-06 16:44:56",
    "code": "688276"
  },
  {
    "title": "百克生物2021年净利2.44亿同比下滑41.77% 总经理孔维薪酬169.91万",
    "href": "http://stock.jrj.com.cn/2022/03/16185334835370.shtml",
    "datetime": "2022-03-16 18:53:03",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：2021年度净利降41.77%至2.44亿元 拟10派1元",
    "href": "http://stock.jrj.com.cn/2022/03/16165334834585.shtml",
    "datetime": "2022-03-16 16:53:21",
    "code": "688276"
  },
  {
    "title": "百克生物2021年净利2.44亿同比减少41.77% 本年度费用化研发支出增加",
    "href": "http://stock.jrj.com.cn/2022/02/18195034395785.shtml",
    "datetime": "2022-02-18 19:50:39",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)业绩快报：2021年归母净利减41.77%至2.44亿元",
    "href": "http://stock.jrj.com.cn/2022/02/18160034391809.shtml",
    "datetime": "2022-02-18 16:00:33",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：选举马骥为公司第五届董事会董事长",
    "href": "http://stock.jrj.com.cn/2021/12/27182034071744.shtml",
    "datetime": "2021-12-27 18:20:49",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：拟聘任大信会计师事务所",
    "href": "http://stock.jrj.com.cn/2021/12/09173433990570.shtml",
    "datetime": "2021-12-09 17:34:00",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：前董事长安吉祥亲属短线交易及致歉",
    "href": "http://stock.jrj.com.cn/2021/11/04181333813550.shtml",
    "datetime": "2021-11-04 18:13:13",
    "code": "688276"
  },
  {
    "title": "百克生物：前三季度净利润2.33亿元，同比下降31.92%",
    "href": "http://stock.jrj.com.cn/2021/10/31223433785507.shtml",
    "datetime": "2021-10-31 22:34:36",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：第三季度净利润降41.73%至9468.88万元",
    "href": "http://stock.jrj.com.cn/2021/10/29162433777556.shtml",
    "datetime": "2021-10-29 16:24:26",
    "code": "688276"
  },
  {
    "title": "百克生物：终止与思安信签署新冠病毒疫苗(PIV-5载体)许可合作协议",
    "href": "http://stock.jrj.com.cn/2021/09/27160933524062.shtml",
    "datetime": "2021-09-27 16:09:33",
    "code": "688276"
  },
  {
    "title": "长春高新(000661.SZ)及百克生物与思安信终止新冠疫苗(PIV-5载体)许可合作",
    "href": "http://stock.jrj.com.cn/2021/09/27160633524052.shtml",
    "datetime": "2021-09-27 16:06:44",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)及长春高新终止与思安信关于新型冠状病毒疫苗(PIV-5载体)的许可合作",
    "href": "http://stock.jrj.com.cn/2021/09/27155133523979.shtml",
    "datetime": "2021-09-27 15:51:43",
    "code": "688276"
  },
  {
    "title": "百克生物上半年营收净利研发投入均降 亮业绩股价连阴",
    "href": "http://stock.jrj.com.cn/2021/08/17153133266812.shtml",
    "datetime": "2021-08-17 15:31:00",
    "code": "688276"
  },
  {
    "title": "百克生物2021年上半年净利1.38亿减少23.06% 水痘疫苗销量下降",
    "href": "http://stock.jrj.com.cn/2021/08/13234433251231.shtml",
    "datetime": "2021-08-13 23:44:20",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：百益制药拟解散并清算",
    "href": "http://stock.jrj.com.cn/2021/08/13211233250702.shtml",
    "datetime": "2021-08-13 21:12:08",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)半年度净利润1.38亿元 同比下降23.06%",
    "href": "http://stock.jrj.com.cn/2021/08/13210933250694.shtml",
    "datetime": "2021-08-13 21:09:28",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：持股5%以上的魏学宁质押300万股",
    "href": "http://stock.jrj.com.cn/2021/08/09222933227632.shtml",
    "datetime": "2021-08-09 22:29:11",
    "code": "688276"
  },
  {
    "title": "百克生物股东魏学宁合计质押300万股 用于资金周转",
    "href": "http://stock.jrj.com.cn/2021/08/09211133227325.shtml",
    "datetime": "2021-08-09 21:11:57",
    "code": "688276"
  },
  {
    "title": "百克生物拟与思安信就新冠疫苗独家生产权利签署协议",
    "href": "http://stock.jrj.com.cn/2021/07/13101833087642.shtml",
    "datetime": "2021-07-13 10:18:27",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：安吉祥辞任董事长等职 马骥接任董事长",
    "href": "http://stock.jrj.com.cn/2021/07/12202033084232.shtml",
    "datetime": "2021-07-12 20:20:09",
    "code": "688276"
  },
  {
    "title": "百克生物上市首日涨226% IPO募15亿两券商赚0.9亿",
    "href": "http://stock.jrj.com.cn/2021/06/25151532996197.shtml",
    "datetime": "2021-06-25 15:15:00",
    "code": "688276"
  },
  {
    "title": "今日上市：嘉益股份、瑞丰银行、百克生物",
    "href": "http://stock.jrj.com.cn/2021/06/25090532994227.shtml",
    "datetime": "2021-06-25 09:05:00",
    "code": "688276"
  },
  {
    "title": "长春高新(000661.SZ)：子公司百克生物明日登陆科创板",
    "href": "http://stock.jrj.com.cn/2021/06/24115032988640.shtml",
    "datetime": "2021-06-24 11:50:06",
    "code": "688276"
  },
  {
    "title": "百克生物：将于6月25日在上交所科创板上市 本次首发4128.41万股新股",
    "href": "http://stock.jrj.com.cn/2021/06/24114632988632.shtml",
    "datetime": "2021-06-24 11:46:27",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：将于6月25日在科创板上市",
    "href": "http://stock.jrj.com.cn/2021/06/23192432984461.shtml",
    "datetime": "2021-06-23 19:24:25",
    "code": "688276"
  },
  {
    "title": "关联交易待审议！百克生物：将在完成科创板上市后择机召开股东大会审议",
    "href": "http://stock.jrj.com.cn/2021/06/22112232975367.shtml",
    "datetime": "2021-06-22 11:22:27",
    "code": "688276"
  },
  {
    "title": "百克生物IPO：经营严重依赖单一品种?2021年业绩堪忧",
    "href": "http://stock.jrj.com.cn/2021/06/22081332974613.shtml",
    "datetime": "2021-06-22 08:13:00",
    "code": "688276"
  },
  {
    "title": "长春高新：百克生物上市后仍为公司并表范围内的子公司",
    "href": "http://stock.jrj.com.cn/2021/06/21194032971061.shtml",
    "datetime": "2021-06-21 19:40:40",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)披露上市发行结果：遭弃购9653股 由联席主承销商包销",
    "href": "http://stock.jrj.com.cn/2021/06/20160332961010.shtml",
    "datetime": "2021-06-20 16:03:36",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)中签结果出炉：中签号码共有1.98万个",
    "href": "http://stock.jrj.com.cn/2021/06/16194632942039.shtml",
    "datetime": "2021-06-16 19:46:13",
    "code": "688276"
  },
  {
    "title": "【兑奖啦】科创板百克生物网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2021/06/16191032941921.shtml",
    "datetime": "2021-06-16 19:10:43",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：网上发行最终中签率为0.02898797%",
    "href": "http://stock.jrj.com.cn/2021/06/15192032936166.shtml",
    "datetime": "2021-06-15 19:20:03",
    "code": "688276"
  },
  {
    "title": "今日申购：百克生物",
    "href": "http://stock.jrj.com.cn/2021/06/15085132932444.shtml",
    "datetime": "2021-06-15 08:51:00",
    "code": "688276"
  },
  {
    "title": "昭衍新药(603127.SH)参与百克生物IPO战略配售 拟获配120万股",
    "href": "http://stock.jrj.com.cn/2021/06/11172032912141.shtml",
    "datetime": "2021-06-11 17:20:15",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：IPO定价36.35元/股 6月15日开启申购",
    "href": "http://stock.jrj.com.cn/2021/06/10192132906587.shtml",
    "datetime": "2021-06-10 19:21:09",
    "code": "688276"
  },
  {
    "title": "百克生物(688276.SH)：网上路演时间2021年6月11日9:00-12:00",
    "href": "http://stock.jrj.com.cn/2021/06/09192532900989.shtml",
    "datetime": "2021-06-09 19:25:33",
    "code": "688276"
  },
  {
    "title": "长春高新：百克生物目前在研产品有冻干人用狂犬病疫苗（Vero细胞）、带状疱疹减毒活疫苗等16个品种",
    "href": "http://stock.jrj.com.cn/2021/06/08145132893190.shtml",
    "datetime": "2021-06-08 14:51:25",
    "code": "688276"
  },
  {
    "title": "集体获批！百克生物、爱威科技、科德数控、东威科技、力芯微科创板IPO注册生效",
    "href": "http://stock.jrj.com.cn/2021/05/13095032746725.shtml",
    "datetime": "2021-05-13 09:50:49",
    "code": "688276"
  },
  {
    "title": "长春高新(000661.SZ)：百克生物科创板IPO注册获证监会同意",
    "href": "http://stock.jrj.com.cn/2021/05/12155732742182.shtml",
    "datetime": "2021-05-12 15:57:35",
    "code": "688276"
  },
  {
    "title": "证监会同意力芯微、爱威科技、东威科技、百克生物、科德数控科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2021/05/11210432737243.shtml",
    "datetime": "2021-05-11 21:04:00",
    "code": "688276"
  },
  {
    "title": "科德数控、百克生物、金冠电气科创板IPO提交注册",
    "href": "http://stock.jrj.com.cn/2021/04/06113732318201.shtml",
    "datetime": "2021-04-06 11:37:17",
    "code": "688276"
  },
  {
    "title": "百克生物IPO：科创属性不足 无证施工被罚",
    "href": "http://stock.jrj.com.cn/2021/03/24081332206727.shtml",
    "datetime": "2021-03-24 08:13:00",
    "code": "688276"
  },
  {
    "title": "百克生物净利增88%现金流为负 单品贡献97%营收狂犬疫苗复产无期",
    "href": "http://stock.jrj.com.cn/ipo/2021/03/22074432322625.shtml",
    "datetime": "2021-03-22 07:44:46",
    "code": "688276"
  },
  {
    "title": "百克生物净利增88%现金流为负 单品贡献97%营收狂犬疫苗复产无期",
    "href": "http://stock.jrj.com.cn/ipo/2021/03/22074432229387.shtml",
    "datetime": "2021-03-22 07:44:46",
    "code": "688276"
  },
  {
    "title": "百克生物净利增88%现金流为负 单品贡献97%营收狂犬疫苗复产无期",
    "href": "http://stock.jrj.com.cn/ipo/2021/03/22074432338935.shtml",
    "datetime": "2021-03-22 07:44:46",
    "code": "688276"
  },
  {
    "title": "A股异动 | 长春高新(000661.SZ)涨超4% 百克生物鼻喷流感减毒活疫苗(液体剂型)获批临试",
    "href": "http://stock.jrj.com.cn/2021/03/03150032063477.shtml",
    "datetime": "2021-03-03 15:00:19",
    "code": "688276"
  },
  {
    "title": "长春高新(000661.SZ)：百克生物鼻喷流感减毒活疫苗(液体剂型)获批临试",
    "href": "http://stock.jrj.com.cn/2021/03/03115332062890.shtml",
    "datetime": "2021-03-03 11:53:05",
    "code": "688276"
  },
  {
    "title": "百克生物科创板IPO过会 销售推广费用、技术先进性遭质疑",
    "href": "http://stock.jrj.com.cn/2021/02/03145731843270.shtml",
    "datetime": "2021-02-03 14:57:09",
    "code": "688276"
  },
  {
    "title": "百克生物过会：今年IPO过关第58家 中信证券过9单",
    "href": "http://stock.jrj.com.cn/2021/02/02105331835336.shtml",
    "datetime": "2021-02-02 10:53:00",
    "code": "688276"
  },
  {
    "title": "科创板IPO|和辉光电、百克生物将于2月1日科创板上会“赴考”",
    "href": "http://stock.jrj.com.cn/2021/01/26153931777146.shtml",
    "datetime": "2021-01-26 15:39:57",
    "code": "688276"
  },
  {
    "title": "长春高新拆分百克生物拟冲科创板 停产狂犬疫苗研发多靠\"体外\"",
    "href": "http://stock.jrj.com.cn/2021/01/26071931772704.shtml",
    "datetime": "2021-01-26 07:19:18",
    "code": "688276"
  },
  {
    "title": "鼻喷式流感疫苗或成长春高新新利润增长点",
    "href": "http://stock.jrj.com.cn/2020/10/28211431152535.shtml",
    "datetime": "2020-10-28 21:14:20",
    "code": "688276"
  },
  {
    "title": "长春高新分拆旗下“四驾马车”之一单独上市 百克生物拟冲击科创板",
    "href": "http://stock.jrj.com.cn/2020/09/14121430746686.shtml",
    "datetime": "2020-09-14 12:14:06",
    "code": "688276"
  },
  {
    "title": "深市首家分拆上市科创板获受理 长春高新旗下百克生物IPO再进一步",
    "href": "http://stock.jrj.com.cn/2020/08/26094730591629.shtml",
    "datetime": "2020-08-26 09:47:12",
    "code": "688276"
  },
  {
    "title": "长春高新：拟分拆百克生物至科创板上市",
    "href": "http://stock.jrj.com.cn/2020/06/11205329901672.shtml",
    "datetime": "2020-06-11 20:53:25",
    "code": "688276"
  },
  {
    "title": "长春高新拟分拆百克生物至科创板上市",
    "href": "http://stock.jrj.com.cn/2020/06/11205229901665.shtml",
    "datetime": "2020-06-11 20:52:14",
    "code": "688276"
  },
  {
    "title": "三家上市公司拟分拆疫苗业务独立上市 长春高新旗下百克生物两年净利增1.4倍",
    "href": "http://stock.jrj.com.cn/2020/05/28081029785032.shtml",
    "datetime": "2020-05-28 08:10:51",
    "code": "688276"
  },
  {
    "title": "长春高新子公司百克生物与FORT签署《专有技术相互许可协议》",
    "href": "http://stock.jrj.com.cn/2019/08/26085728031256.shtml",
    "datetime": "2019-08-26 08:57:25",
    "code": "688276"
  }
]